Drug Testing Lab Services

City of Tulsa Finance Department
10/26/2026
REQUEST FOR PROPOSAL FOR BID TAC 585M
Addendum #2
Please note the following changes which have been made for clarification to this Invitation for Sealed Bid. This
addendum must be listed as Addendum #2 on the ACKNOWLEDGMENT OF RECEIPT OF
ADDENDA/AMENDMENTS FORM of the bid package as verification that you have received and are aware
of the information contained herein.
QUESTIONS/CLARIFICATION/CHANGES:
CLARIFICATION: The Nextgen software's bi-directional interface is in HL7 v2 format.

City of Tulsa Finance Department
10/16/2026
REQUEST FOR PROPOSAL FOR BID TAC 585M
Addendum #1
Please note the following changes which have been made for clarification to this Invitation for Sealed Bid. This
addendum must be listed as Addendum #1 on the ACKNOWLEDGMENT OF RECEIPT OF
ADDENDA/AMENDMENTS FORM of the bid package as verification that you have received and are aware
of the information contained herein.
QUESTIONS/CLARIFICATION/CHANGES:
CLARIFICATION: Miscellaneous typographical and grammatical errors have been
corrected.
CHANGE 1. Exhibit A was missing Estimated Quantities for evaluation purposes.
Quantities have been listed.
2

City of Tulsa Finance Department
Request for Proposal
TAC 585M
Professional Services for: Drug Testing Laboratory Services
De partment: Human Resources
NI GP Commodity Code(s): 952-07, 961-50
RFP Schedule
EVENT DATE
RFP Issue Date 10/12/2026
Pre-Proposal Conference 10/16/2026 at 09:00 am CDT
Virtual - email buyer for invite
Deadline for Questions 10/26/2026
Submit to assigned buyer via email. 10 Days prior to RFP due date
Proposal Due Date 11/04/2026
Mail or deliver to City Clerk address. Proposals
are opened the day after the due date.
If You have any questions or need additional information, contact the Assigned Buyer:
Samantha J. Toothaker, Senior Buyer | stoothaker@cityoftulsa.org
All questions should be emailed with TAC 585M on the subject line.
Sub mit proposals (sealed) to:
Office of the City Clerk
City of Tulsa
175 E. 2ND St.
Suite 260
Tulsa, OK 74103
3

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
I. OVERVIEW AND GOALS
The City of Tulsa (City) is soliciting proposals to secure a source to provide Drug Testing
Laboratory services for the City Medical division of the Human Resources Department.
We enthusiastically look forward to receiving Your proposal.
II. BACKGROUND
The Respondent must furnish DOT and non-DOT drug testing laboratory services and report
results to the City Medical division who oversees drug testing for City applicants and City
employees. All laboratory test results should be securely electronically transferred into the
City's occupational health software. We are currently using Nextgen electronic health record
system software and have a bi-directional interface for orders and results.
III. TIMELINE
The schedule below provides estimated dates for the RFP and contracting process. The
City of Tulsa may adjust this schedule as needed.
EVENT DATE
RFP Issue Date 10/12/2026
Pre-Proposal Conference 10/16/2026
Deadline for Questions 10/26/2026
Addenda issued (if needed) 10/28/2026
PROPOSAL DUE DATE 11/04/2026
Begin proposal evaluations 11/05/2026
Proposal Award (anticipated) 11/12/2026
Negotiations with apparent successful Respondent begin (anticipated) 11/12/2026
Execute contract (anticipated) 12/02/2026
Begin service delivery (anticipated) 12/04/2026
4

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
IV. SCOPE OF WORK
The Respondent shall provide the following services:
Respondent shall provide daily pickup services from City Medical's primary location.
Respondent shall provide all specimen collection supplies. All specimen collections will
be conducted by City Medical.
Custody control forms will be used and maintained with all samples provided to
Respondent for processing. Respondent must provide effective sample tracking along
with a robust chain of custody system to ensure end-to-end visibility of specimen samples
while in transit.
If samples are being transported via a freight carrier instead of local courier, Respondent
is to provide prepaid airbills. Freight and/or courier expenses are to be included in unit
costs listed in Exhibit A and may not be billed to City as an individual line item.
All prices quoted shall be based on F.O.B. Tulsa, Oklahoma, with all charges prepaid by
Respondent to the actual point of delivery at the testing laboratory from the pick-up point
in Tulsa, Oklahoma. Any potential freight charges must be included in your unit cost.
Respondent shall provide consultations with a board-certified scientist or toxicologist on
an on-call basis. Cost of consultations must be included in your unit cost.
Occasionally it may be necessary for Respondent to provide onsite expert witness
testimony. The day rate listed on Exhibit A must be all inclusive of necessary costs to
provide the service.
Respondent shall provide access to their Directory of Services with their proposal packet.
If it is a website requiring a login, appropriate credentials to review service listings must
be provided.
Drug test results must be reported within 24 hours unless positive. Please list the time
frame for reporting all positive tests.
Specimen validity testing/Adulterant screening must be completed on all samples
submitted for initial drug testing.
All positive tests must have quantitative levels reported. All confirmatory tests shall be
completed via gas chromatography-mass spectrometry (GC-MS) methodology.
Results are to be sent via secure portal and positive preliminary results faxed to City
Medical's secure fax.
Annual report showing test panel usage summaries for previous 12 month period must be
provided to the Assigned Buyer with annual contract renewal paperwork.
5

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
Drug Testing Table
Abbreviation Analyte Initial Test Level Confirmatory Test Level
Amphetamines
AMP Amphetamine 500 ng/mL 250 ng/mL
MAMP Methamphetamine 500 ng/mL 250 ng/mL
MDMA Methylenedioxymethamphetamine 500 ng/mL 250 ng/mL
MDA Methylenedioxyamphetamine 500 ng/mL 250 ng/mL
Opioids
COD Codeine 2000 ng/mL 2000 ng/mL
MOP Morphine 2000 ng/mL 2000 ng/mL
Semi-Synthetic Opioid (Heroin)
6-AM 6-Acetylmorphine (Heroin metabolite) 10 ng/mL 10 ng/mL
Semi-Synthetic Opioids
HYC Hydrocodone 300 ng/mL 100 ng/mL
HYM Hydromorphone 300 ng/mL 100 ng/mL
OXYC Oxycodone 100 ng/mL 100 ng/mL
OXYM Oxymorphone 100 ng/mL 100 ng/mL
Synthetic Opioids
FENT Fentanyl* 1 ng/mL 1 ng/mL
NFENT Norfentanyl 1 ng/mL 1 ng/mL
MTD Methadone 300 ng/mL 200 ng/mL
MEP Meperidine 100 ng/mL 100 ng/mL
PPX Propoxyphene** 300 ng/mL 300 ng/mL
TRAM Tramadol 100 ng/mL 100/ng/mL
Other
THC Marijuana Metabolite (delta9THCC) 50 ng/mL 15 ng/mL
COC Cocaine (Benzoylecgonine) 150 ng/mL 100 ng/mL
BAR Barbiturates 300 ng/mL 200 ng/mL
BZO Benzodiazepines 300 ng/mL 200 ng/mL
MQL Methaqualone** 300 ng/mL 300 ng/mL
PCP Phencyclidine 25 ng/mL 25 ng/mL
* a fentanyl immunoassay must have at least 5% cross-reactivity to norfentanyl
**specific to Oklahoma State Regulations
6

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
Specimen Validity Testing Parameters - Adulterant Screening (SVT)
Abbreviation Parameter Normal Dilute Substituted Adulterated
CR Creatinine 20.0 mg/dL 2.0 - 19.9 < 2.0
SG Specific Gravity 1.0020 - 1.0200 1.0010 - 1.0029 1.0010
PH pH 4.5 - 8.9 < 4.0 or 11.0
NIT Nitrite Negative 500 mcg/mL
NOTE: City is aware of pending changes to the DOT test panel requirements with regard to
adding Fentanyl and Norfentanyl. Please utilize Item 1a and 2a on Exhibit A to list Order Code
and pricing for those panel configurations once the rule is finalized and has gone into effect.
V. DELIVERABLES
The products, reports, and services to be delivered to City will include specimen collection
supplies, specimen testing results, on-call consultation services and expert testimony.
VI. RESPONDENT QUALIFICATIONS
The City of Tulsa is seeking a full-service laboratory that is accredited by the Commission on
Inspection and Accreditation of Laboratories of the College of American Pathologists. The City
of Tulsa has opted to do only SAMHSA drug tests therefore the lab must be certified by the
Department of Health and Human Services. The lab should be licensed to operate in interstate
commerce by the Centers for Disease Control of the Department of Health and Human Services
and licensed by the Federal Nuclear Regulatory commission for radioimmunoassay. Respondent
must be an actual laboratory, not a third party administrator. Accreditation Certificates must be
submitted with Proposal Packet.
VII. INSTRUCTIONS FOR SUBMITTING A PROPOSAL:
A. Proposals must be received by 5:00 p.m. Central Time on the Bid Submission Date
(see first page). Please place proposals in a sealed envelope or box clearly labeled
"TAC 585M, Drug Testing Laboratory Services". Please use the label provided on the
last page of this RFP to clearly write the Respondent's legal name and Bid number on the
outside of the package, container, or envelope. No faxed or emailed Bids will be
considered.
Proposals received late will be returned unopened.
B. Interested Respondents should submit:
One (1) unbound original.
One (1) bound copy with either binder clip or staple. Do not use spiral, comb or thermal
binding.
C. Proposals shall be delivered and sealed to:
Office of the City Clerk
City of Tulsa
175 E. 2nd St.
Suite 260
Tulsa, OK 74103
7

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
D. Pre-Bid Conference: If a pre-Bid conference is required, see the first page for time and
location.
Attendance Requirement
Attendance at the Pre-Bid Conference is required to submit a Bid.
Attendance is not required to submit a Bid.
E. All interested Respondents (Sellers) are required to register with the Buyer in order to
receive updates, addenda or any additional information required. You can learn more
about the registration process on the following website:
https://www.cityoftulsa.org/government/departments/finance/selling-to-the-city/register-
as-a-vendor/.
The City is not responsible for any failure to register.
F. Inquiries or questions to the Buyer requesting clarification regarding the Request for
Proposal must be made via e-mail and must be received at least 10 Days prior to the
Bid Submission Date.
Samantha J. Toothaker, Senior Buyer
stoothaker@cityoftulsa.org
Any questions regarding this RFP will be handled as promptly and as directly as possible.
If a question requires only minor clarification of instructions or specifications, it will be
handled via e-mail. If any question results in a substantive change or addition to the RFP,
the change or addition will be forwarded to all registered Respondents as quickly as
possible by addendum.
G. Data Rider: (Exhibit B) If the box is checked "Yes," the Data Rider is required.
Yes: No:
H. Insurance: (Exhibit C) If the box is checked "Yes," Insurance Requirements as set forth
in Exhibit C are required.
Yes: No:
I. Proposals will be opened on the morning after the due date, at 8:30am, at the:
Standards, Specifications, and Awards Committee Meeting
175 East 2nd Street, 2nd Floor
City Council Chamber
8

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
VIII. RESPONSE QUESTIONS AND PROPOSAL REQUIREMENTS
To be considered, interested Respondents should submit or address the following requirements:
Timeframe to integrate with NextGen software.
Ability to respond to Daily pickup requests.
Timeframe for reporting confirmed positive test results.
Minimum five (5) references to be provided. References must include Company's
name, contact's name, full mailing address, phone number, email address and a
description of the supplies and/or services provided.
Directory of Services access
Accreditation Certificates for Laboratory and personnel
Required Forms
Respondent Information Sheet
Exhibit A Delivery and Price Sheet Summary
Exhibit B Data Rider
Exhibit C Insurance - Certificate(s) of Insurance
Exhibit D City of Tulsa General Contract Terms
Affidavit of Non-Collusion, Interest and Claimant
Acknowledgement of Receipt of Addenda/Amendments
Signatory Authorization Documentation for Authorized Agent if necessary based on
signer's title and entity's legal structure. Reference Section X Miscellaneous, letter L.
Authorized Agents.
IX. EVALUATION OF PROPOSALS:
A panel consisting of not less than three (3) City of Tulsa employees will conduct a
comprehensive, fair and impartial evaluation of all proposals received in response to this RFP.
Final selection shall be the sole determination of the City, and if a selection is made it will be
to the Respondent whose proposal is determined to be in the best interests of the City. The
approval of the selected Respondent will be subject to the final determination of the City and
will be contingent on the successful completion of a contract between the City and the selected
9

TAC 585M | Drug Testing Laboratory Services | Issue Date: 10/12/2026
Respondent(s). The City's determination may consider technical merit, qualifications,
demonstrated experience, overall value, and the Respondent's ability to successfully perform
Scope of Work. The City reserves the right to conduct interviews, request presentations, or
seek clarifications from one or more Respondents as part of the evaluation process, and may
be considered in the final evaluation.
All Proposals will be evaluated using the following criteria:
Category Total Points
Qualifications and Experience 40
Service Delivery 30
Pricing and Cost Proposal 20
Staff Capacity and Oversight 10
Total Possible Points 100
The City of Tulsa also reserves the right to evaluate based on the full list of eligible criteria
listed in Title 6, Chapter 4 of the Tulsa Revised Ordinances (TRO):
https://library.municode.com/ok/tulsa/codes/code_of_ordinances.
X. MISCELLANEOUS
A. The City expects to enter into a written Agreement (the "Agreement") with the chosen
Respondent(s) that shall incorporate this RFP and your proposal. Further, Respondent(s)
will be bound to comply with the provisions set forth in this RFP. In addition to any terms
and conditions included in this RFP, the City may include in the Agreement other terms
and conditions as deemed necessary. Your response to this RFP will be considered part
of the Agreement if one is awarded to you.
B. All data included in this RFP, as well as any attachments, are proprietary to the City.
C. The City notifies all possible Respondents that no person shall be excluded from
participation in, denied any benefits of, or otherwise discriminated against in connection
with the award and performance of any contract on the basis of race, religious creed, color,
national origin, ancestry, physical disability, sex, age, ethnicity, or on any other basis
prohibited by law.
D. All Respondents shall comply with all applicable laws regarding equal employment
opportunity and nondiscrimination. They shall also comply with the Americans with
Disabilities Act (ADA).
E. The use of the City's name in any way as a potential customer or contractual partner is
strictly prohibited except as authorized in writing by the City.
F. The City assumes no responsibility or liability for any costs you may incur in responding
to this RFP, including attending meetings or contract negotiations.
G. The City is bound to comply with Oklahoma's Open Records Act, and information
submitted with your proposal, with few exceptions, is a matter of public record. For
10